Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.

NCT02236156 is registered in ClinicalTrials.gov with Starpharma Pty Ltd as lead sponsor.

NCT NCT02236156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02236156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis.
Lead sponsor
Starpharma Pty Ltd
Phase
Phase 3
Overall status
Completed
Start date
October 3, 2014
Completion date
October 4, 2016
Enrollment
637 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis